MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Waters Corp

Geschlossen

BrancheGesundheitswesen

287.21 -3.35

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

284.48

Max

297.07

Schlüsselkennzahlen

By Trading Economics

Einkommen

-110M

121M

Verkäufe

-211M

662M

KGV

Branchendurchschnitt

27.628

39.857

EPS

2.25

Gewinnspanne

18.344

Angestellte

7,600

EBITDA

-193M

152M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+33.71% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.2B

18B

Vorheriger Eröffnungskurs

290.56

Vorheriger Schlusskurs

287.21

Nachrichtenstimmung

By Acuity

65%

35%

318 / 376 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Waters Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Juli 2025, 14:26 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14. Juli 2025, 11:08 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15. Juli 2025, 18:32 UTC

Akquisitionen, Fusionen, Übernahmen

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15. Juli 2025, 18:31 UTC

Akquisitionen, Fusionen, Übernahmen

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14. Juli 2025, 16:53 UTC

Heiße Aktien

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14. Juli 2025, 16:12 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14. Juli 2025, 15:06 UTC

Akquisitionen, Fusionen, Übernahmen

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14. Juli 2025, 14:11 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14. Juli 2025, 10:53 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14. Juli 2025, 10:22 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14. Juli 2025, 10:22 UTC

Akquisitionen, Fusionen, Übernahmen

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14. Juli 2025, 10:22 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14. Juli 2025, 10:21 UTC

Akquisitionen, Fusionen, Übernahmen

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14. Juli 2025, 10:20 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14. Juli 2025, 10:19 UTC

Akquisitionen, Fusionen, Übernahmen

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14. Juli 2025, 10:19 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14. Juli 2025, 10:18 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14. Juli 2025, 10:18 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14. Juli 2025, 10:17 UTC

Akquisitionen, Fusionen, Übernahmen

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14. Juli 2025, 10:16 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14. Juli 2025, 10:16 UTC

Akquisitionen, Fusionen, Übernahmen

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14. Juli 2025, 10:15 UTC

Akquisitionen, Fusionen, Übernahmen

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14. Juli 2025, 10:15 UTC

Akquisitionen, Fusionen, Übernahmen

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Peer-Vergleich

Kursveränderung

Waters Corp Prognose

Kursziel

By TipRanks

33.71% Vorteil

12-Monats-Prognose

Durchschnitt 397 USD  33.71%

Hoch 500 USD

Tief 330 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Waters Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

13 ratings

6

Buy

7

Halten

0

Sell

Technischer Score

By Trading Central

345.22 / 351.01Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

318 / 376 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.